Last updated on June 2019

A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered Locally Advanced or Metastatic Triple-Negative Breast Cancer or Hormone Receptor-Positive HER2-Negative Breast Cancer


Brief description of study

This study will evaluate the efficacy of ipatasertib + paclitaxel versus placebo + paclitaxel in participants with histologically confirmed, locally advanced or metastatic triple-negative breast cancer (TNBC) and in participants with locally advanced or metastatic hormone receptor positive (HR+)/ human epidermal growth factor receptor 2 negative (HER2) breast adenocarcinoma who are not suitable for endocrine therapy.

Clinical Study Identifier: NCT03337724

Find a site near you

Start Over

UCSD Moores Cancer Center

La Jolla, CA United States
  Connect »

Kaiser Permanente - Oakland

Oakland, CA United States
  Connect »

Emad Ibrahim, Md, Inc

Redlands, CA United States
  Connect »

Kaiser Permanente - Roseville

Roseville, CA United States
  Connect »

K. Permanente - San Jose

San Jose, CA United States
  Connect »

Kaiser Permanente - San Leandro

San Leandro, CA United States
  Connect »

K. Permanente - Santa Clara

Santa Clara, CA United States
  Connect »

Kaiser Permanente - South San Francisco

South San Francisco, CA United States
  Connect »

Kaiser Permanente - Vallejo

Vallejo, CA United States
  Connect »

K. Permanente - Walnut Creek

Walnut Creek, CA United States
  Connect »

Memorial Regional Hospital

Hollywood, FL United States
  Connect »

Memorial Hospital West

Pembroke Pines, FL United States
  Connect »

University of Maryland

Baltimore, MD United States
  Connect »

Mercy Medical Center

Baltimore, MD United States
  Connect »

Memorial Sloan Kettering

New York, NY United States
  Connect »

Mid Ohio Onc Hematology Inc

Columbus, OH United States
  Connect »

West Clinic

Germantown, TN United States
  Connect »

Brig Cancer Care

Knoxville, TN United States
  Connect »

Texas Oncology, P.A.

Dallas, TX United States
  Connect »

Clinica CIMCA

San Jose, Costa Rica
  Connect »

ICM; Medecine B3

Montpellier cedex 5, France
  Connect »

National Cancer Center

Gyeonggi-do, Korea, Republic of
  Connect »

Clinical Hospital; Oncology Department

Bitola, Macedonia, The Former Yugoslav Republic of
  Connect »

Moscow City Oncology Hospital #62

Moscovskaya Oblast, Russian Federation
  Connect »

Velindre Cancer Centre

Cardiff, United Kingdom
  Connect »

Royal Stoke University Hospital

Stoke on Trent, United Kingdom
  Connect »

Beijing Hospital

Beijing City, China
  Connect »

Inha University Hospital

Incheon, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

USC Norris Cancer Center

Los Angeles, CA United States
  Connect »

UCSF Comprehensive Cancer Ctr

San Francisco, CA United States
  Connect »

Oncology Consultants PA

Houston, TX United States
  Connect »

Hospital Britanico

Ciudad Autonoma Bs As, Argentina
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.